BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P1H
REFRESH-INTERVAL:P1H
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
DTSTART:20070101T000000
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:Mountain Daylight Time
END:DAYLIGHT
BEGIN:STANDARD
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
DTSTART:20070101T000000
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:Mountain Standard Time
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20260429T090000
DTEND;TZID=America/Denver:20260429T100000
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:NIH Technology Opportunity Webinar: Novel Small Molecule Targeting Dopamine D3 Receptor
DESCRIPTION:APRIL 29\, 2026\n9:00 - 10:00 AM MTRegister to attend a free NIH webinar. Attendees will learn about a new non-opioid small molecule for treating Opioid Use and Substance Use Disorders by selectively targeting the Dopamine D3 receptor. Dr. Amy Newman and her NIH team discovered this new molecule that will advance to a clinical trial. Register
X-ALT-DESC;FMTTYPE=text/html:
APRIL 29\, 2026
9:00 - 10:00 AM MT
Register to attend a free NIH webinar. Attendees will learn about a new non-opioid small molecule for treating Opioid Use and Substance Use Disorders by selectively targeting the Dopamine D3 receptor. Dr. Amy Newman and her NIH team discovered this new molecule that will advance to a clinical trial. \;
Register »\;
LOCATION:
UID:e.4358.1446521
SEQUENCE:3
DTSTAMP:20260418T124157Z
URL:https://bioutah.growthzoneapp.com/eventscalendar/Details/nih-technology-opportunity-webinar-novel-small-molecule-targeting-dopamine-d3-receptor-1713249?sourceTypeId=Hub
END:VEVENT
END:VCALENDAR